A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs | Cell Research
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines
Immunoglobulin germline gene variation and its impact on human disease | Genes & Immunity
Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants | Nature Communications
Population matched (pm) germline allelic variants of immunoglobulin (IG) loci: Relevance in infectious diseases and vaccination studies in human populations | Genes & Immunity
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses - ScienceDirect
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines
The evolutionary and functional significance of germline immunoglobulin gene variation: Trends in Immunology
Microorganisms | Free Full-Text | SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments
Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2 | Scientific Reports
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2 - eClinicalMedicine
Frontiers | Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron - ScienceDirect
Vaccines | Free Full-Text | Immune Control of Avian Influenza Virus Infection and Its Vaccine Development
Immunoglobulin germline gene variation and its impact on human disease | Genes & Immunity
Viruses | Free Full-Text | COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
Frontiers | Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children - Turner - 2020 - Clinical & Experimental Immunology - Wiley Online Library
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera - ScienceDirect
Vaccines | Free Full-Text | A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain | Nature Communications
